News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Antonio Calles: Final overall survival of MARIPOSA trial
Antonio Calles/ruberinternacional.es
Mar 26, 2025, 13:38

Antonio Calles: Final overall survival of MARIPOSA trial

Antonio Calles, Head of the Lung Cancer Unit at Ruber International Hospital, shared a post on X:

“Prof Yang presents final overall survival of MARIPOSA trial.

HR 0.75 (95% CI 0.61-0.92) Osimertinib 36.7 months vs not reached for Amivantamab and lazertinib.”

Antonio Calles: Final overall survival of MARIPOSA trial

Amivantamab Antonio Calles cancer fight against cancer Global fight against cancer Hospital Ruber Internacional lazertinib Lung cancer MARIPOSA OncoDaily Oncology osimertinib Prof Yang
Special Coverage
Societies
Jun 15, 2025, 15:57
ESMO Elections 2025: Results
Blog
Jun 15, 2025, 15:49
Michael Sapienza: We Pride Ourselves on Using the Latest Technology to Maximize Our Reach and Impact at the Colorectal Cancer Alliance
Blog
Jun 15, 2025, 15:39
IASLC Will Host Live Webinar on 2025 ASCO Highlights
Blog
Jun 15, 2025, 15:28
CAR-T Cell Therapy Extended Survival by 40% in Patients With Advanced Gastric Cancer - Cancer Research Institute
Blog
Jun 15, 2025, 15:17
Ricky Frazer: An Absolute Privilege to Present World Leading Experts in Cancer Vaccine Development at UKOF25
Blog
Jun 15, 2025, 15:03
Tiago Biachi de Castria Was Elected as a Member-at-Large On The Medical Staff Committee at Moffitt Cancer Center
Blog
Jun 15, 2025, 14:59
Registration is Open for the HORIZON Global Forum - Jarurat Care Foundation
Blog
Jun 15, 2025, 14:48
Hung Trinh: BioNTech and Bristol Myers Squibb Partner on $11.1 Billion Cancer Immunotherapy Deal
Blog
Jun 15, 2025, 14:32
Peter Pisters Expresses Gratitude to MD Anderson Cancer Center Care Teams For Consistently Providing Exceptional Care to Patients
Blog
Jun 15, 2025, 14:23
Olubukola Ayodele: The Person Who Starts Cancer Treatment Isn't The Same Person Who Finishes It
Blog
Jun 15, 2025, 14:21
Ruben Mesa: Honored to Have Been The Senior Author of The Plenary Abstract of the Phase III SURPASS-ETs Trial at EHA25
Blog
Jun 15, 2025, 14:09
Douglas Flora: Kentucky’s Lung Cancer Control Program Now Ranks N1 Nationally